These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4398214)

  • 1. Hemodynamic effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956): a nonadrenergic myocardial stimulant.
    Osborne MW; Wenger JJ; Moe RA
    J Pharmacol Exp Ther; 1971 Jan; 176(1):174-83. PubMed ID: 4398214
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro myocardial effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956).
    Kline RL; Buckley JP
    J Pharmacol Exp Ther; 1972 Sep; 182(3):399-408. PubMed ID: 4403432
    [No Abstract]   [Full Text] [Related]  

  • 3. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac effects of isoproterenol during graded myocardial ischemia.
    Lekven J; Kjekshus JK; Mjös OD
    Scand J Clin Lab Invest; 1974 Apr; 33(2):161-71. PubMed ID: 4850884
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of sotalol and propranolol on myocardial contractility.
    Gomoll AW; Braunwald E
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
    [No Abstract]   [Full Text] [Related]  

  • 7. Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).
    Somani P; Laddu AR
    J Pharmacol Exp Ther; 1969 Nov; 170(1):72-8. PubMed ID: 4390814
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac actions of oxprenolol as studied in dog heart-lung preparations.
    Takeda K; Iizuka H; Imai S
    Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692
    [No Abstract]   [Full Text] [Related]  

  • 9. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.
    Giles RE; Williams JC; Finkel MP
    J Pharmacol Exp Ther; 1973 Sep; 186(3):472-81. PubMed ID: 4147005
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the beta-adrenergic blocking agentnethalide on some hemodynamic indices in experiment].
    Gorodinskaia VIa
    Farmakol Toksikol; 1968; 31(1):15-8. PubMed ID: 4386335
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of isoproterenol on the hemodynamics and contractibility of the left ventricle before and after Gubernal].
    Schönbeck M; Krayenbühl HP; Wirz P; Mahler F; Rutishauser W
    Schweiz Med Wochenschr; 1971 Jul; 101(29):1061-7. PubMed ID: 4398193
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of a sodium lactate perfusion on the hemodynamic effects of beta-blockaders].
    Scebat A; Castan L; Renais R; Chiche J; Fernandez F; Gerbaux A
    Arch Mal Coeur Vaiss; 1978 Mar; 71(3):306-13. PubMed ID: 25055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further observations on the cardiovascular effects of ST 155 (Catapres).
    Nayler WG; Price JM; Stone J; Lowe TE
    J Pharmacol Exp Ther; 1969 Apr; 166(2):364-73. PubMed ID: 5776992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the beta receptor blocking properties of two analogs of dichloroisoproterenol (DCI).
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):123-33. PubMed ID: 4146700
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of volume loading on the inotropic effect of Ro 7-2956.
    Osborne MW; Wenger JJ; Zanko MT; Barrett RJ
    Eur J Pharmacol; 1974 Sep; 28(1):1-10. PubMed ID: 4372062
    [No Abstract]   [Full Text] [Related]  

  • 18. The selective beta receptor blocking properties of DL-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane HC1 (M & B 17803-A) in the anesthetized dog.
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):134-44. PubMed ID: 4146701
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial effects of phentolamine.
    Das PK; Parratt JR
    Br J Pharmacol; 1970 Sep; 40(1):150P-151P. PubMed ID: 4395081
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative cardiac effects of isoxsuprine and nylidrin following administration of doses producing equivalent skeletal muscle vasodilatation.
    Lawson JW; Manley ES
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):67-77. PubMed ID: 5551203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.